Nagpur
+919405117673
+919405117673

Oxaliplatin 50mg Injection Exporter from India | Cordium Pharmaceuticals Pvt Ltd – Global Supply

Oxaliplatin 50mg Injection is a platinum-based chemotherapy medication widely used in modern oncology protocols for the treatment of colorectal cancer and other advanced malignancies. It plays a crucial role in combination chemotherapy regimens by slowing or stopping the growth of cancer cells. Manufacturer & Global Exporter Cordium Pharmaceuticals Pvt Ltd is a trusted India-based global pharmaceutical exporter specializing in high-quality injectable oncology drugs with strict quality compliance and international supply standards. We ensure fast and reliable delivery worldwide including: United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. Medical Usage of Oxaliplatin 50mg Injection Oxaliplatin is commonly used in: Treatment of metastatic colorectal cancer Adjuvant therapy after surgical removal of tumors Combination chemotherapy regimens (such as FOLFOX protocol) Management of advanced gastrointestinal cancers Dosage Information (General Guidance) Administered intravenously under medical supervision only Dosage is determined by an oncologist based on body surface area (BSA), patient condition, and treatment protocol Typically used in cycles as part of combination chemotherapy ⚠️ Self-administration is strictly not recommended. Possible Side Effects Patients may experience: Nausea and vomiting Fatigue and weakness Peripheral neuropathy (tingling or numbness in hands and feet) Low blood cell count (immunosuppression risk) Allergic reactions in rare cases Loss of appetite Medical supervision and regular monitoring are essential during treatment. Why Choose Cordium Pharmaceuticals Pvt Ltd WHO-GMP compliant manufacturing standards High-quality oncology injectables Global export network Secure packaging and cold-chain logistics (as required) Fast international delivery support Business Contact Information 📞 WhatsApp: +91-9405117673 📧 Email: info@cordiumpharma.com
 2026-04-18T05:47:59

Keywords